SCHEMBL2906645

SCHEMBL2906645

CS(=O)(=O)N(c1cc(O)ccc1O)C1CN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 4/20 0.36
POLB P06746 2/20 0.35
CYP3A4 P08684 1/20 0.34
CYP3A5 P20815 1/20 0.34
CNR2 P34972 1/20 0.34
GPX4 P36969 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33
CACNA2D1 P54289 1/20 0.32
CACNA1B Q00975 1/20 0.32
CACNB1 Q02641 1/20 0.32
CACNA1C Q13936 1/20 0.32
OPRM1 P35372 1/20 0.32
OPRD1 P41143 1/20 0.32
CYP2D6 P10635 2/20 0.32
CHRM2 P08172 1/20 0.32
HTR1A P08908 1/20 0.32
ADRA2A P08913 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2906643 0.82 CACNA2D1 (0.39) SLC6A9POLBCYP3A4CYP3A5GPX4
SCHEMBL4711968 0.78 CYP3A4 (0.42) SLC6A9CYP3A4CYP3A5GPX4KDM4E
SCHEMBL976065 0.77 SLC6A9 (0.38) SLC6A9GPX4MEN1KMT2AKDM4E
Drinabant SCHEMBL684143 0.76 CYP3A4 (0.36) SLC6A9CYP3A4CYP3A5GPX4CACNA2D1
SCHEMBL2906510 0.75 MAPT (0.38) SLC6A9POLBCYP3A4CYP3A5OPRD1
SCHEMBL975245 0.74 SLC6A9 (0.39) SLC6A9CYP3A4CYP3A5GPX4CACNA2D1
SCHEMBL975170 0.74 SLC6A9 (0.38) SLC6A9CYP3A4CYP3A5MEN1KMT2A
SCHEMBL977045 0.73 CACNA2D1 (0.41) SLC6A9CNR2MEN1KMT2AKDM4E
SCHEMBL2909614 0.73 CACNA2D1 (0.39) SLC6A9POLBCYP3A4CYP3A5GPX4
SCHEMBL4927549 0.72 GPR84 (0.37) SLC6A9CYP3A4CYP3A5GPX4CACNA2D1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1263722-B1 PHARMACEUTICAL COMPOSITIONS CONTAINING AZETIDINE DERIVATIVES, NOVEL AZETIDINE DERIVATIVES AND PREPARATION THEREOF AVENTIS PHARMA SA (FR) 2010-08-25 EP claimed
EP-1328269-B1 ASSOCIATION OF A CB1 RECEPTOR ANTAGONIST AND SIBUTRAMIN FOR TREATING OBESITY AVENTIS PHARMA SA (FR) 2004-05-26 EP claimed